In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following council meeting.
Times and Dates:
8:30 a.m.-5:30 p.m., October 7, 2008.
8:30 a.m.-2 p.m., October 8, 2008.
Place: Corporate Square, Building 8, 1st Floor Conference Room, Atlanta, Georgia 30333, Telephone (404) 639-8317.
Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people.
Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis.
Matters to be Discussed: Agenda items include issues pertaining to update on nucleic acid amplification guidelines; update on interferon gamma release assays guidelines; update on the isolation guidelines; update on travel restrictions guidelines and other related tuberculosis issues.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Margie Scott-Cseh, Coordinating Center for Infectious Diseases, Strategic Business Unit, 1600 Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, Telephone (404) 639-8317.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: September 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).
[FR Doc. E8-22040 Filed 9-19-08; 8:45 am]
BILLING CODE 4163-18-P